GENZYME APPROACHING 100 PATIENTS ON CEREDASE: $ 20,000-$ 60,000 PER YEAR GAUCHER DISEASE DRUG AVAILABLE FOR WIDER USE AND REIMBURSEMENT AFTER FDA OKAY